 Solbec unsuccessfully sought a business partner to develop coramsine further, abandoning its development, as they changed the company's direction as well as its legal business name in December 2008, following the US investment market's late-2008 turmoil and ensuing credit crunch.The subsequent company licensed the technology back to the original founder, Bill Cham, who manufactures it from his private company in Vanuatu and markets it worldwide via the internet under the name Curaderm BEC5, a cream of solasodine rhamnosyl glycosides (BEC).Curaderm BEC5 has not been approved for medical use by any regulatory agency.